Association of race, heart failure and chronic kidney disease

Albert Yuh-Jer Shen1, Somjot S Brar, Steven S Khan

  • 1Division of Cardiology, Department of Medicine, Kaiser Permanente Los Angeles Medical Center, 1526 North Edgemont Street, Los Angeles, CA 90027, USA. albert.y-j.shen@kp.org

Future Cardiology
|October 7, 2009
PubMed

Insights

Heart failure and kidney disease are growing epidemics affecting many adults. Racial disparities exist in disease causes and treatment responses, necessitating inclusive research.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health
  • Health Disparities

Background:

  • Heart failure and kidney disease are significant, growing public health concerns.
  • Approximately 50% of heart failure patients have co-existing kidney disease.
  • Racial and ethnic groups exhibit different primary causes for these conditions, including hypertension, ischemic heart disease, and diabetic kidney disease.

Purpose of the Study:

  • To highlight the prevalence and co-occurrence of heart failure and kidney disease.
  • To examine racial and ethnic variations in the etiologies of these diseases.
  • To underscore the need for research that addresses racial differences in disease burden and treatment response.

Main Methods:

  • Review of existing epidemiological data and clinical guidelines.
  • Analysis of disease distribution across different racial and ethnic populations.
  • Synthesis of current understanding regarding racial variations in therapeutic responses.

Main Results:

  • One in nine US adults has kidney disease, with a high comorbidity with heart failure.
  • Hypertension is a major cause in Black populations, ischemic heart disease in Whites, and diabetic kidney disease in Hispanics.
  • Minority populations disproportionately bear the burden of these diseases.
  • Emerging evidence suggests racial differences in drug responsiveness.

Conclusions:

  • The co-occurrence of heart failure and kidney disease presents a substantial public health challenge.
  • Understanding and addressing racial and ethnic disparities in disease etiology and outcomes is critical.
  • Future research must incorporate diverse populations to elucidate and account for racial differences in disease progression and treatment efficacy.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...